S
Samumed
Biotech company developing novel therapeutics for regenerative medicine and oncology.
Rate
About
Samumed is a private, clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs that activate the Wnt/beta-catenin pathway. Their research targets a wide range of diseases, including degenerative conditions, oncology, and fibrosis.
Technology stack
detected 2026-06-18Est. monthly stack spend~$110/mo
Email
Microsoft 365
Stack
Tailwind CSS
Bootstrap
Analytics
Google Analytics 4
Segment
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Samumed do?
Samumed is a private, clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs that activate the Wnt/beta-catenin pathway. Their research targets a wide range of diseases, including degenerative conditions, oncology, and fibrosis.
Where is Samumed headquartered?
Samumed is headquartered in San Diego, United States.
When was Samumed founded?
Samumed was founded in 1997.
What industry does Samumed operate in?
Samumed operates in Biotech, MedTech, Drug Discovery, Clinical Trials, Regenerative Medicine, Oncology.